A Multicenter, Prospective Randomized Controlled Modified Dual Platform Trial Evaluating Several Cellular, Acellular, and Matrix-Like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers (TIGERCAMP). ijtr 2025, 1 (Suppl 2). https://doi.org/10.63676/njbsev63.